Rob A. de Man

2.9k total citations
64 papers, 1.9k citations indexed

About

Rob A. de Man is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Rob A. de Man has authored 64 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hepatology, 30 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Rob A. de Man's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (17 papers) and Hepatitis B Virus Studies (15 papers). Rob A. de Man is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (17 papers) and Hepatitis B Virus Studies (15 papers). Rob A. de Man collaborates with scholars based in Netherlands, United States and Canada. Rob A. de Man's co-authors include Jan N.M. IJzermans, Pieter E. Zondervan, Shahid M. Hussain, Ernst J. Kuipers, Türkan Terkivatan, Solko W. Schalm, Bettina E. Hansen, Sjoerd de Rave, Ewout J. Hoorn and Joost van der Hoek and has published in prestigious journals such as Gastroenterology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Rob A. de Man

63 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob A. de Man Netherlands 25 1.1k 801 560 266 262 64 1.9k
John Boletis Greece 28 531 0.5× 555 0.7× 420 0.8× 247 0.9× 449 1.7× 154 3.0k
Vijayan Balan United States 27 1.5k 1.4× 1.1k 1.4× 732 1.3× 136 0.5× 226 0.9× 63 2.3k
Eytan Mor Israel 26 1.1k 1.0× 974 1.2× 865 1.5× 157 0.6× 248 0.9× 109 2.6k
Yeon Seok Seo South Korea 25 1.2k 1.1× 1.0k 1.3× 473 0.8× 466 1.8× 395 1.5× 141 2.3k
M. Colledan Italy 30 1.6k 1.5× 841 1.0× 1.7k 3.1× 444 1.7× 322 1.2× 172 3.0k
Andrea Duchini United States 18 527 0.5× 588 0.7× 328 0.6× 159 0.6× 145 0.6× 30 1.3k
Michael Gschwantler Austria 26 1.3k 1.2× 1.3k 1.6× 528 0.9× 284 1.1× 307 1.2× 132 2.4k
Surakit Pungpapong United States 27 1.0k 1.0× 1.2k 1.5× 978 1.7× 490 1.8× 318 1.2× 103 2.3k
W. Keith Hoots United States 34 410 0.4× 586 0.7× 377 0.7× 196 0.7× 191 0.7× 97 4.2k
I. J. Klompmaker Netherlands 28 910 0.8× 718 0.9× 1.0k 1.8× 264 1.0× 149 0.6× 61 2.0k

Countries citing papers authored by Rob A. de Man

Since Specialization
Citations

This map shows the geographic impact of Rob A. de Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob A. de Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob A. de Man more than expected).

Fields of papers citing papers by Rob A. de Man

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob A. de Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob A. de Man. The network helps show where Rob A. de Man may publish in the future.

Co-authorship network of co-authors of Rob A. de Man

This figure shows the co-authorship network connecting the top 25 collaborators of Rob A. de Man. A scholar is included among the top collaborators of Rob A. de Man based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob A. de Man. Rob A. de Man is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willemssen, François E.J.A., Rob A. de Man, Aad van der Lugt, et al.. (2024). Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study. European Radiology Experimental. 8(1). 29–29. 1 indexed citations
2.
Buti, Marı́a, Özgür M. Koc, Kosh Agarwal, et al.. (2023). Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe. Journal of Hepatology. 80(2). 243–250. 8 indexed citations
3.
Starmans, Martijn P. A., Razvan L. Miclea, Valérie Vilgrain, et al.. (2023). Automated Assessment of T2-Weighted MRI to Differentiate Malignant and Benign Primary Solid Liver Lesions in Noncirrhotic Livers Using Radiomics. Academic Radiology. 31(3). 870–879. 6 indexed citations
4.
Biewenga, Maaike, Sebastiaan Heidt, Rob A. de Man, et al.. (2022). B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis. JHEP Reports. 4(5). 100460–100460. 8 indexed citations
5.
Choi, Hannah, Milan J. Sonneveld, Mina Farag, et al.. (2021). Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection. Journal of Viral Hepatitis. 28(12). 1729–1737. 8 indexed citations
6.
Berg, A. P. van den, Bart van Hoek, Wojciech G. Polak, et al.. (2018). ['Will I receive a liver transplant in time?'; chance of survival of patients on the liver transplant waiting list].. PubMed. 162. D2159–D2159. 1 indexed citations
7.
Bremmer, Rolf H., M.A.M.T. Verhagen, Vivian E. Ekkelenkamp, et al.. (2018). Is Textbook Outcome a valuable composite measure for short-term outcomes of gastrointestinal treatments in the Netherlands using hospital information system data? A retrospective cohort study. BMJ Open. 8(2). e019405–e019405. 36 indexed citations
8.
Sideras, Kostandinos, Steven Bots, Katharina Biermann, et al.. (2015). Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area. British Journal of Cancer. 112(12). 1911–1920. 38 indexed citations
9.
Pas, Suzan D., Rob A. de Man, Aggie H.M.M. Balk, et al.. (2012). Hepatitis E Virus Infection among Solid Organ Transplant Recipients, the Netherlands. Emerging infectious diseases. 18(5). 869–872. 130 indexed citations
10.
Gerven, Nicole M. F. van, Bart J. Verwer, Birgit I. Lissenberg‐Witte, et al.. (2012). Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. Journal of Hepatology. 58(1). 141–147. 155 indexed citations
11.
Vries-Sluijs, T.E.M.S. de, Jurriën G.P. Reijnders, Bettina E. Hansen, et al.. (2010). Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus. Gastroenterology. 139(6). 1934–1941. 85 indexed citations
12.
Nicolaas, Jerome Sint, et al.. (2010). Colorectal Cancer in Post-Liver Transplant Recipients. Diseases of the Colon & Rectum. 53(5). 817–821. 13 indexed citations
13.
Leeuwenburgh, Ivonne, et al.. (2008). Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkinʼs lymphoma, fully reversible after chemotherapy. European Journal of Gastroenterology & Hepatology. 20(2). 145–147. 25 indexed citations
14.
Wolfhagen, Frank H.J., et al.. (2008). Initially obscure hepatotoxicity attributed to sildenafil. European Journal of Gastroenterology & Hepatology. 20(7). 710–712. 10 indexed citations
15.
Bos, Indra C. van den, Shahid M. Hussain, Roy S. Dwarkasing, et al.. (2007). Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma. British Journal of Radiology. 80(960). e317–e320. 15 indexed citations
16.
Plas, Simone M. van der, Bettina E. Hansen, Josien B. de Boer, et al.. (2006). Generic and disease-specific health related quality of life of liver patients with various aetiologies: A survey. Quality of Life Research. 16(3). 375–388. 39 indexed citations
17.
Dekken, Herman van, Cees Verhoef, Ronald van Marion, et al.. (2005). Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis. Acta Histochemica. 107(3). 161–171. 12 indexed citations
18.
Verhoef, Cornelis, Raymond G.J. Pot, Rob A. de Man, et al.. (2003). Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology. 15(11). 1171–1174. 44 indexed citations
19.
Agthoven, Michel van, Herold J. Metselaar, Hugo W. Tilanus, et al.. (2001). A comparison of the costs and effects of liver transplantation for acute and for chronic liver failure. Transplant International. 14(2). 87–94. 29 indexed citations
20.
Man, Rob A. de, R. A. Heijtink, Hubert G.M. Niesters, & Solko W. Schalm. (1995). New Developments in Antiviral Therapy for Chronic Hepatitis B Infection. Scandinavian Journal of Gastroenterology. 30(sup212). 100–104. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026